Topics

Qurient Co. Ltd. Company Profile

20:07 EST 16th February 2020 | BioPortfolio

Qurient is a clinical-stage biopharmaceutical company listed in Korea Exchange (KRX 115180). Qurient has two programs in clinical development and one program in the IND enabling stage. Q301 is a topical leukotriene inhibitor for atopic dermatitis in a Phase 2b clinical trial in the United States. Q702 is a Axl/Mer/CSF1R triple inhibitor for immune-oncology and drug resistant non-small cell lung cancer, licensed from Max Planck Innovation and Lead Discovery Center in Germany. Telacebec (Q203), which just completed Phase 2a clinical trial, was licensed from Institute of Pasteur in Korea. For more info, please visit www.qurient.com.


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Qurient Co. Ltd.

Qurient is a clinical-stage biopharmaceutical company listed in Korea Exchange (KRX 115180). Qurient has two programs in clinical development and one program in the IND enabling s...

More Information about "Qurient Co. Ltd." on BioPortfolio

We have published hundreds of Qurient Co. Ltd. news stories on BioPortfolio along with dozens of Qurient Co. Ltd. Clinical Trials and PubMed Articles about Qurient Co. Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Qurient Co. Ltd. Companies in our database. You can also find out about relevant Qurient Co. Ltd. Drugs and Medications on this site too.

Quick Search

Relevant Topics

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...


Corporate Database Quicklinks



Searches Linking to this Company Record